Spencer promotes blood flow imaging device
Spencer Technologies of Seattle has filed a 510(k) with the FDA to market a new transcranial Doppler device: a noninvasive combination of hardware and software that helps clinicians image and track blood flow with ultrasound. The company is
Spencer Technologies of Seattle has filed a 510(k) with the FDA to market a new transcranial Doppler device: a noninvasive combination of hardware and software that helps clinicians image and track blood flow with ultrasound.
The company is developing five proprietary Doppler ultrasound products addressing the detection, prevention, and treatment of conditions leading to stroke, pulmonary embolism, deafness, and cranial hemorrhage. The transcranial Doppler technology is designed to help diagnose conditions that may lead to stroke, according to the firm.
Spencer Technologies president and CEO Scott Seidel said customers will replace older analog ultrasound technology with this product.
Some ultrasound systems use harmonic imaging to visualize blood activity. The difference between transcranial Doppler and harmonic imaging is that the former images blood flow, while the latter visualizes the outline of blood vessels, Seidel said.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
